Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database

Background: Pancreatitis is characterized by inflammation of the pancreas and significantly affects quality of life. Less than 5% of pancreatitis cases are drug-induced, but recent evidence suggests a substantial risk associated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The aim of...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Khalidah A. Alenzi, Deemah Alsuhaibani, Bader Batarfi, Thamir M. Alshammari
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-05-01
Subjects:	drug-induced glucagon-like peptide-1 inhibitors of dipeptidyl peptidase 4 (DPP-4) pancreatitis sodium-glucose transport protein 2 (SGLT2) inhibitors
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1364110/full